(Q44445942)

English

KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups

scientific article published on 11 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Narongrit Sritana

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Chirayu U Auewarakul

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

11 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

227-231

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Mutations of the FLT3 gene in adult acute myeloid leukemia: determination of incidence and identification of a novel mutation in a Thai population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Targeting receptor tyrosine kinase signaling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Molecular genetics of human leukemias: new insights into therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Low frequency of KIT gene mutation in pediatric acute myeloid leukemia with inv(16)(p13q22): a study of the Japanese Childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

The molecular pathogenesis of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Disruption of differentiation in human cancer: AML shows the way.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.09.004

7 January 2021

Identifiers

10.1016/J.YEXMP.2008.09.004

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44445942&oldid=2024443794"